46.35
BATS BZX Real-Time Price
As of 9:47am ET
 +0.175 / +0.38%
Today’s Change
40.00
Today|||52-Week Range
47.11
+6.76%
Year-to-Date
Here's Why Dermira Stock Is Rocketing Higher Today
Oct 18 / MotleyFool.com - Paid Partner Content
Should Investors Buy or Sell Sangamo Therapeutics Right Now?
Oct 08 / MotleyFool.com - Paid Partner Content
Big Pharma Has Mad Love For These 2 Biotechs
Oct 11 / MotleyFool.com - Paid Partner Content
Heres Why Emergent BioSolutions Stock Climbed 19.4% in September
Oct 07 / MotleyFool.com - Paid Partner Content
Why Amicus Therapeutics Stock Folded in September
Oct 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close46.17
Today’s open46.38
Day’s range46.30 - 46.41
Volume18,001
Average volume (3 months)1,497,553
Market cap$115.0B
Data as of 9:47am ET, 10/21/2019

Growth & Valuation

Earnings growth (last year)+19.94%
Earnings growth (this year)+3.64%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+2.83%
P/E ratio29.0
Price/Sales2.68
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.10-0.23%
ABBVAbbVie-0.37-0.48%
GSKGlaxoSmithKline+0.03+0.07%
LLYEli Lilly and Co-0.20-0.18%
Data as of 9:48am ET, 10/21/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)$0.94
Annual revenue (last year)$40.7B
Annual profit (last year)$5.1B
Net profit margin12.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Paris, Ile-de-france

Forecasts